Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 1/20 | 0.36 |
| ▸ | APP | P05067 | 2/20 | 0.32 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28830693 | 1.00 | MAOB (0.36) | MAOBAPPTRPA1ALDH1A1LMNA | |
| SCHEMBL294613 | 0.91 | APP (0.39) | MAOBAPP | |
| SCHEMBL294614 | 0.91 | APP (0.39) | MAOBAPP | |
| SCHEMBL152100 | 0.78 | MAOB (0.33) | MAOBAPPTRPA1ALDH1A1LMNA | |
| SCHEMBL210914 | 0.78 | MAOB (0.33) | MAOBAPPTRPA1ALDH1A1LMNA | |
| SCHEMBL787790 | 0.75 | ALDH1A1 (0.58) | MAOBAPPTRPA1ALDH1A1LMNA | |
| SCHEMBL93419 | 0.74 | MAOB (0.68) | MAOBTRPA1ALDH1A1LMNAALOX5 | |
| SCHEMBL4445282 | 0.74 | ALDH1A1 (0.61) | MAOBAPPTRPA1ALDH1A1LMNA | |
| SCHEMBL33879 | 0.74 | MAOB (0.68) | MAOBTRPA1ALDH1A1LMNAALOX5 | |
| SCHEMBL4936136 | 0.74 | MAOB (0.68) | MAOBTRPA1ALDH1A1LMNAALOX5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109695660-B | Glass apron processing shock attenuation platform | 江苏摩臣智联科技有限公司 | 2021-08-06 | — | — | CN | disclosed |
| CN-102850336-A | DERIVATIVES OF 4-PIPERAZIN-1-YL-4-BENZ0 [B] THIOPHENE SUITABLE FOR THE TREATMENT OF CNS DISORDERS | OTSUKA PHARMA CO LTD | 2013-01-02 | — | — | CN | disclosed |
| CN-100490212-C | Method and apparatus for manufacturing active-matrix organic EL display, active-matrix organic EL display, method for manufacturing liquid crystal array, liquid crystal array, filter substrate, method | SHARP KK KONICA MINOLTA HOLDIN (JP) | 2009-05-20 | — | — | CN | disclosed |
| EP-1919907-A2 | HETEROCYCLIC COMPOUND | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2008-05-14 | — | — | EP | disclosed |
| WO-2007026959-A2 | DERIVATIVES OF 4-PIPERAZIN-1-YL-4-BENZ0 [B] THIOPHENE SUITABLE FOR THE TREATMENT OF CNS DISORDERS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2007-03-08 | — | — | WO | disclosed |
| CN-1701641-A | Method and apparatus for manufacturing active-matrix organic EL display, active-matrix organic EL display, method for manufacturing liquid crystal array, liquid crystal array, method and apparatus for | SHARP KK (JP) | 2005-11-23 | — | — | CN | disclosed |
| US-6420409-B1 | GLUCOSE TOLERANCE, DIABETES,INSULIN RESISTANCE, POLYCYSTIC OVARY SYNDROME, HYPERLIPIDEMIA, ATHEROSCLEROSIS, CARDIOVASCULAR DISORDERS, HYPERGLYCEMIA, HYPERTENSION, STENOCARDIA, PULMONARY HYPERTENSION, CONGESTIVE HEART FAILURE, | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2002-07-16 | — | — | US | disclosed |
| EP-1020452-A1 | BENZIMIDAZOLE DERIVATIVES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2000-07-19 | — | — | EP | disclosed |